The board of directors at Chameleon Biosciences is made up of experienced professionals from a variety of backgrounds and industries. Many of the members have experience in academia, holding positions such as professor or research scientist at renowned institutions such as Stanford University and Columbia University Medical Center. Others come from the business world, having worked in regulatory affairs or as consultants for companies in the drug development industry. With such a diverse range of experiences, the board is equipped to provide valuable insights and guidance to the company as it looks to continue its success in the biotechnology industry.
Casey Maguire
Co-Founder & Advisor
David W. Scott
Advisor
Elizabeth Berry-Krav...
Advisor
Genine Winslow
Founder, CEO & Board President
Mark Kay
Advisor
Mary Newman
Executive Advisor, Regulatory ...
Michio Hirano
Advisor
Ran Geng
Board Member
Raphael Clynes
Board Member
Suyash Prasad
Executive Clinical Advisor
Thomas Chalberg
Board Member
Winnie Wan
Board Member
View all